CAPECITABINE

CAPECITABINE was reported 92086 times

CAPECITABINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 154 0.7230
1 FINGERPRINT LOSS 74 0.4568
2 PIK3CA-ACTIVATED MUTATION 115 0.3464
3 DYSAESTHESIA PHARYNX 56 0.3200
4 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6732 0.2885
5 TUMOUR PERFORATION 77 0.2421
6 PSEUDOCIRRHOSIS 73 0.2199
7 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 51 0.2134
8 METASTASES TO EYE 46 0.2100
9 SKIN CHAPPED 81 0.2005
10 ANASTOMOTIC LEAK 135 0.1945
11 METASTASES TO SKIN 176 0.1704
12 ANASTOMOTIC COMPLICATION 58 0.1686
13 NAIL BED INFLAMMATION 53 0.1661
14 METASTASES TO THE MEDIASTINUM 65 0.1578
15 NON-CIRRHOTIC PORTAL HYPERTENSION 57 0.1516
16 ARTERIOSPASM CORONARY 593 0.1477
17 METASTASES TO CHEST WALL 50 0.1441
18 HER2 POSITIVE BREAST CANCER 54 0.1440
19 MUCOSAL TOXICITY 39 0.1439
20 GASTROINTESTINAL ANASTOMOTIC LEAK 53 0.1359
21 CARBOHYDRATE ANTIGEN 15-3 INCREASED 103 0.1353
22 METASTASES TO PLEURA 141 0.1344
23 GASTROENTERITIS RADIATION 39 0.1189
24 BREAST CANCER METASTATIC 1248 0.1161
25 GASTROINTESTINAL TOXICITY 524 0.1090
26 METASTASES TO LIVER 1863 0.1059
27 CARCINOEMBRYONIC ANTIGEN INCREASED 201 0.1037
28 TERMINAL ILEITIS 61 0.0993
29 METASTASES TO PERITONEUM 248 0.0981
30 RADIATION SKIN INJURY 113 0.0974
31 METASTASES TO LUNG 1037 0.0897
32 COLON CANCER METASTATIC 140 0.0868
33 METASTASES TO CENTRAL NERVOUS SYSTEM 1082 0.0838
34 RECTAL PERFORATION 45 0.0835
35 METASTASES TO LYMPH NODES 551 0.0816
36 METASTASES TO BONE 1336 0.0813
37 PANCREATIC NEUROENDOCRINE TUMOUR 52 0.0811
38 EJECTION FRACTION 47 0.0809
39 NASAL MUCOSAL DISORDER 46 0.0789
40 MUCOSAL INFLAMMATION 2012 0.0768
41 ONYCHOLYSIS 119 0.0761
42 ENTERITIS 487 0.0760
43 METASTASES TO ADRENALS 70 0.0758
44 SKIN TOXICITY 426 0.0753
45 LYMPHANGIOSIS CARCINOMATOSA 77 0.0739
46 TUMOUR MARKER INCREASED 351 0.0731
47 RECALL PHENOMENON 61 0.0730
48 COLORECTAL CANCER METASTATIC 172 0.0725
49 PARONYCHIA 305 0.0693
50 ENTEROCOLITIS 397 0.0687
51 TOXIC LEUKOENCEPHALOPATHY 49 0.0675
52 METASTASES TO SPINE 225 0.0669
53 NODULAR REGENERATIVE HYPERPLASIA 42 0.0654
54 LARYNGOSPASM 176 0.0654
55 MALIGNANT ASCITES 49 0.0639
56 PRIMARY SEQUESTRUM 57 0.0629
57 ACUTE PROMYELOCYTIC LEUKAEMIA 64 0.0623
58 ABDOMINAL LYMPHADENOPATHY 53 0.0611
59 BREAST CANCER RECURRENT 189 0.0598
60 GASTROINTESTINAL PERFORATION 240 0.0577
61 METASTASES TO MENINGES 130 0.0571
62 STREPTOCOCCAL SEPSIS 67 0.0565
63 PORTAL HYPERTENSION 164 0.0531
64 DEVICE RELATED THROMBOSIS 52 0.0527
65 METASTASIS 373 0.0522
66 DISEASE PROGRESSION 6113 0.0516
67 HEPATIC LESION 222 0.0513
68 CARDIOTOXICITY 457 0.0512
69 OSTEOSCLEROSIS 80 0.0508
70 BONE MARROW TOXICITY 60 0.0506
71 PRINZMETAL ANGINA 50 0.0503
72 NAIL INFECTION 71 0.0495
73 METASTATIC NEOPLASM 213 0.0493
74 VASCULAR PAIN 47 0.0493
75 HAEMATOTOXICITY 466 0.0490
76 PERIPHERAL SENSORY NEUROPATHY 282 0.0482
77 TUMOUR PAIN 63 0.0478
78 HYPERAMMONAEMIC ENCEPHALOPATHY 83 0.0477
79 HEPATIC CANCER METASTATIC 40 0.0467
80 DILATED CARDIOMYOPATHY 47 0.0465
81 NEUROTOXICITY 809 0.0461
82 PALMAR ERYTHEMA 53 0.0460
83 BREAST NEOPLASM 47 0.0455
84 ABDOMINAL SEPSIS 40 0.0454
85 PROTEIN URINE 41 0.0453
86 BONE LESION 160 0.0443
87 INVASIVE DUCTAL BREAST CARCINOMA 120 0.0441
88 TUMOUR NECROSIS 46 0.0435
89 HEMIANOPIA 43 0.0433
90 SUBILEUS 89 0.0427
91 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 76 0.0427
92 PERIPHERAL MOTOR NEUROPATHY 59 0.0421
93 OBSTRUCTION GASTRIC 53 0.0412
94 ADENOCARCINOMA OF COLON 77 0.0411
95 COMPUTERISED TOMOGRAM ABNORMAL 93 0.0410
96 PELVIC ABSCESS 47 0.0409
97 ONYCHALGIA 41 0.0409
98 HYPERBILIRUBINAEMIA 413 0.0398
99 PROCTITIS 111 0.0396
100 MALIGNANT NEOPLASM PROGRESSION 4033 0.0393
101 NEOPLASM PROGRESSION 1363 0.0392
102 MYELOSUPPRESSION 1386 0.0384
103 MALIGNANT PLEURAL EFFUSION 64 0.0379
104 RECTAL TENESMUS 47 0.0377
105 HYPOALBUMINAEMIA 293 0.0376
106 HOSPICE CARE 372 0.0376
107 OSTEOLYSIS 76 0.0371
108 RECURRENT CANCER 150 0.0367
109 NAIL DISORDER 321 0.0367
110 GASTRIC PERFORATION 99 0.0363
111 NEUTROPENIC COLITIS 75 0.0362
112 BONE MARROW FAILURE 724 0.0356
113 BILE DUCT OBSTRUCTION 67 0.0353
114 EXPOSED BONE IN JAW 76 0.0350
115 STOMATITIS 2127 0.0350
116 ONYCHOMADESIS 147 0.0350
117 ADENOCARCINOMA 78 0.0348
118 HEPATIC MASS 67 0.0348
119 AORTIC THROMBOSIS 40 0.0346
120 VARICES OESOPHAGEAL 103 0.0340
121 PHARYNGEAL INFLAMMATION 41 0.0337
122 LEUKOENCEPHALOPATHY 124 0.0333
123 PSEUDOMONAL SEPSIS 58 0.0331
124 ARTERIAL THROMBOSIS 64 0.0331
125 GASTROINTESTINAL STOMA COMPLICATION 51 0.0324
126 LYMPHADENOPATHY MEDIASTINAL 61 0.0318
127 GRANULOCYTE COUNT DECREASED 59 0.0318
128 SKIN FISSURES 616 0.0315
129 WOUND DEHISCENCE 106 0.0313
130 NEUTROPENIC SEPSIS 223 0.0312
131 NEUROPATHY PERIPHERAL 2958 0.0311
132 THERAPY PARTIAL RESPONDER 478 0.0306
133 HYPOVOLAEMIC SHOCK 146 0.0304
134 DYSAESTHESIA 92 0.0300
135 DERMATITIS ACNEIFORM 178 0.0292
136 STOMA SITE HAEMORRHAGE 45 0.0292
137 HYPERTRIGLYCERIDAEMIA 171 0.0292
138 VENOOCCLUSIVE LIVER DISEASE 144 0.0291
139 HEPATIC NEOPLASM 95 0.0291
140 BREAST DISORDER 59 0.0289
141 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 95 0.0287
142 SMALL INTESTINAL PERFORATION 53 0.0282
143 PNEUMATOSIS INTESTINALIS 80 0.0280
144 ASCITES 819 0.0278
145 ILEUS 342 0.0275
146 GASTROINTESTINAL INJURY 74 0.0275
147 NEOPLASM RECURRENCE 93 0.0274
148 RECTAL CANCER 83 0.0270
149 PERIODONTITIS 58 0.0268
150 POLYNEUROPATHY 318 0.0265
151 LIVER ABSCESS 86 0.0265
152 PERFORMANCE STATUS DECREASED 123 0.0263
153 EJECTION FRACTION DECREASED 402 0.0258
154 STRIDOR 75 0.0255
155 PANCREATIC CARCINOMA METASTATIC 72 0.0253
156 VENTRICULAR FIBRILLATION 280 0.0252
157 EARLY SATIETY 49 0.0252
158 BLOOD BILIRUBIN INCREASED 680 0.0251
159 LYMPHOEDEMA 171 0.0247
160 NAIL DISCOLOURATION 96 0.0244
161 PORTAL VEIN THROMBOSIS 78 0.0241
162 INGROWING NAIL 57 0.0241
163 FEMALE GENITAL TRACT FISTULA 41 0.0240
164 HICCUPS 195 0.0237
165 LARGE INTESTINAL OBSTRUCTION 53 0.0237
166 INTESTINAL PERFORATION 264 0.0235
167 VOCAL CORD PARALYSIS 42 0.0234
168 HYPERAESTHESIA 192 0.0233
169 LEUKOPENIA 1164 0.0232
170 NEUTROPENIA 3161 0.0232
171 HYPOPROTEINAEMIA 44 0.0232
172 AZOTAEMIA 92 0.0230
173 THROMBOCYTOPENIA 2573 0.0230
174 ILEUS PARALYTIC 102 0.0228
175 HYPOKALAEMIA 1048 0.0227
176 PERIPHERAL ISCHAEMIA 92 0.0225
177 EMBOLISM VENOUS 68 0.0224
178 SMALL INTESTINAL OBSTRUCTION 275 0.0223
179 CANCER PAIN 57 0.0223
180 ELECTROLYTE IMBALANCE 259 0.0223
181 CACHEXIA 114 0.0221
182 LEFT VENTRICULAR DYSFUNCTION 148 0.0221
183 EMBOLISM 183 0.0220
184 BLOOD CREATININE DECREASED 69 0.0220
185 ORAL INTAKE REDUCED 53 0.0219
186 PARAPARESIS 39 0.0219
187 PIGMENTATION DISORDER 134 0.0217
188 CHEILITIS 117 0.0216
189 DIARRHOEA 13789 0.0213
190 SOFT TISSUE INFECTION 39 0.0213
191 OSTEONECROSIS OF JAW 521 0.0210
192 TUMOUR HAEMORRHAGE 60 0.0210
193 NEOPLASM 241 0.0209
194 OESOPHAGITIS 229 0.0209
195 NEUTROPHIL COUNT ABNORMAL 59 0.0209
196 DEHYDRATION 2767 0.0207
197 VASCULAR DEVICE INFECTION 94 0.0207
198 PROCTALGIA 133 0.0207
199 BLOOD ALBUMIN DECREASED 164 0.0207
200 HEPATIC CYST 70 0.0206
201 INTESTINAL ISCHAEMIA 113 0.0205
202 TEMPERATURE INTOLERANCE 211 0.0204
203 PROTEINURIA 387 0.0203
204 LARGE INTESTINE PERFORATION 141 0.0203
205 GENE MUTATION 40 0.0202
206 ACUTE CORONARY SYNDROME 166 0.0200
207 SKIN HYPERPIGMENTATION 172 0.0200
208 CHOLANGITIS 124 0.0200
209 JAUNDICE CHOLESTATIC 70 0.0198
210 DYSCHEZIA 60 0.0196
211 NEUROLOGICAL DECOMPENSATION 45 0.0194
212 SKIN DISCOLOURATION 887 0.0193
213 VENOUS THROMBOSIS 75 0.0191
214 HYDRONEPHROSIS 143 0.0191
215 LUNG NEOPLASM 81 0.0189
216 GASTROINTESTINAL NECROSIS 55 0.0188
217 NECROTISING FASCIITIS 66 0.0187
218 MOUTH ULCERATION 393 0.0186
219 BRAIN OPERATION 42 0.0184
220 PULMONARY MASS 274 0.0184
221 OESOPHAGEAL STENOSIS 52 0.0183
222 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 40 0.0182
223 DERMATOMYOSITIS 46 0.0181
224 CLOSTRIDIAL INFECTION 61 0.0180
225 ALANINE AMINOTRANSFERASE ABNORMAL 38 0.0180
226 HEPATIC FUNCTION ABNORMAL 670 0.0179
227 INTESTINAL OBSTRUCTION 676 0.0179
228 FEBRILE NEUTROPENIA 1188 0.0179
229 COLITIS 676 0.0178
230 ATELECTASIS 170 0.0176
231 PATHOLOGICAL FRACTURE 89 0.0175
232 PARESIS 39 0.0175
233 AORTIC ARTERIOSCLEROSIS 45 0.0175
234 BLOOD MAGNESIUM DECREASED 148 0.0171
235 DISSEMINATED INTRAVASCULAR COAGULATION 240 0.0170
236 GASTROINTESTINAL OBSTRUCTION 41 0.0170
237 LIP BLISTER 46 0.0169
238 ODYNOPHAGIA 100 0.0167
239 ONYCHOCLASIS 114 0.0165
240 LEFT VENTRICULAR FAILURE 56 0.0163
241 SECOND PRIMARY MALIGNANCY 135 0.0162
242 PROTEIN TOTAL DECREASED 61 0.0162
243 PLEURAL EFFUSION 980 0.0161
244 HYPERAMMONAEMIA 80 0.0160
245 NEUTROPHIL COUNT DECREASED 650 0.0159
246 ISCHAEMIA 73 0.0159
247 HYPOPHOSPHATAEMIA 117 0.0158
248 STRESS CARDIOMYOPATHY 92 0.0158
249 PROTEIN TOTAL INCREASED 42 0.0158
250 PNEUMONITIS 419 0.0154
251 CONGESTIVE CARDIOMYOPATHY 64 0.0153
252 HYPOVOLAEMIA 89 0.0152
253 COLON CANCER 225 0.0151
254 THERAPY CHANGE 148 0.0150
255 HEPATOTOXICITY 334 0.0150
256 HEPATIC FAILURE 452 0.0150
257 PURULENT DISCHARGE 63 0.0147
258 BRAIN OEDEMA 185 0.0146
259 LIP PAIN 42 0.0146
260 DRUG TOLERANCE DECREASED 41 0.0146
261 ORAL PAIN 326 0.0145
262 GASTROINTESTINAL INFLAMMATION 114 0.0145
263 PLEURITIC PAIN 40 0.0145
264 CREPITATIONS 43 0.0144
265 TONGUE DISCOLOURATION 63 0.0144
266 SKIN EXFOLIATION 1213 0.0144
267 BRAIN NEOPLASM 132 0.0144
268 DECREASED APPETITE 3316 0.0143
269 BONE MARROW DISORDER 43 0.0142
270 JAUNDICE 379 0.0141
271 HYPOMAGNESAEMIA 196 0.0141
272 BONE DISORDER 256 0.0140
273 MALNUTRITION 157 0.0140
274 VENTRICULAR HYPOKINESIA 45 0.0140
275 SUDDEN DEATH 148 0.0140
276 LOOSE TOOTH 45 0.0140
277 ORAL DISORDER 102 0.0139
278 GINGIVITIS 75 0.0139
279 FIBROSIS 42 0.0136
280 AORTIC DISSECTION 56 0.0135
281 VOMITING 6344 0.0135
282 KERATITIS 41 0.0135
283 ARTERIOSCLEROSIS CORONARY ARTERY 89 0.0134
284 BLOOD PHOSPHORUS DECREASED 49 0.0134
285 MYOCARDIAL ISCHAEMIA 152 0.0133
286 HYPERTRANSAMINASAEMIA 92 0.0132
287 BODY TEMPERATURE DECREASED 130 0.0132
288 ANOREXIA 169 0.0131
289 BLOOD ALKALINE PHOSPHATASE INCREASED 321 0.0129
290 ANAEMIA 2428 0.0127
291 HYPOCALCAEMIA 239 0.0126
292 SKIN REACTION 177 0.0126
293 THROMBOPHLEBITIS 44 0.0125
294 PERICARDIAL EFFUSION 290 0.0125
295 TENDERNESS 130 0.0125
296 PLATELET COUNT DECREASED 1328 0.0124
297 CEREBRAL ISCHAEMIA 64 0.0124
298 PANCYTOPENIA 690 0.0123
299 RED CELL DISTRIBUTION WIDTH INCREASED 51 0.0123
300 COMPRESSION FRACTURE 65 0.0121
301 BLOOD LACTATE DEHYDROGENASE INCREASED 192 0.0121
302 WOUND COMPLICATION 41 0.0119
303 FAILURE TO THRIVE 62 0.0119
304 NEPHROTIC SYNDROME 81 0.0118
305 BLOOD POTASSIUM DECREASED 355 0.0118
306 BACTERAEMIA 140 0.0118
307 THERAPY INTERRUPTED 841 0.0118
308 DUODENAL ULCER 83 0.0118
309 HEPATIC PAIN 50 0.0117
310 PROTHROMBIN TIME PROLONGED 70 0.0117
311 BLISTER 654 0.0116
312 PULMONARY EMBOLISM 1104 0.0116
313 GINGIVAL BLEEDING 158 0.0116
314 COLITIS ISCHAEMIC 78 0.0116
315 OBSTRUCTION 46 0.0115
316 TRISMUS 59 0.0114
317 HAEMOLYTIC ANAEMIA 102 0.0114
318 TOOTH EXTRACTION 141 0.0113
319 AORTIC VALVE INCOMPETENCE 48 0.0113
320 TRANSAMINASES INCREASED 250 0.0112
321 ASPARTATE AMINOTRANSFERASE INCREASED 597 0.0112
322 FISTULA 126 0.0112
323 GAMMA-GLUTAMYLTRANSFERASE INCREASED 248 0.0112
324 CYSTITIS HAEMORRHAGIC 45 0.0112
325 SEPSIS 1239 0.0111
326 URINARY TRACT DISORDER 50 0.0111
327 GINGIVAL SWELLING 49 0.0111
328 ABDOMINAL ABSCESS 49 0.0111
329 KLEBSIELLA INFECTION 56 0.0111
330 OCULAR ICTERUS 48 0.0111
331 HEPATIC CYTOLYSIS 141 0.0110
332 HYPERKERATOSIS 61 0.0110
333 VARICOSE VEIN 57 0.0110
334 THERAPY CESSATION 565 0.0110
335 LYMPHADENOPATHY 388 0.0109
336 COAGULOPATHY 182 0.0109
337 PULMONARY TOXICITY 77 0.0109
338 WHITE BLOOD CELL COUNT DECREASED 1179 0.0109
339 LIVER INJURY 266 0.0108
340 NAUSEA 8547 0.0108
341 CARDIAC TAMPONADE 51 0.0107
342 PNEUMOTHORAX 170 0.0107
343 ATAXIA 127 0.0107
344 DIARRHOEA HAEMORRHAGIC 100 0.0107
345 MASS 149 0.0107
346 GINGIVAL PAIN 84 0.0105
347 HYPOPHAGIA 269 0.0105
348 SPLENOMEGALY 123 0.0105
349 CIRCULATORY COLLAPSE 178 0.0104
350 CANDIDA INFECTION 176 0.0104
351 OSTEOMYELITIS 188 0.0104
352 THROMBOTIC MICROANGIOPATHY 101 0.0104
353 DEATH 8917 0.0103
354 BREAST CANCER 964 0.0103
355 FAECES SOFT 75 0.0103
356 PAIN IN JAW 292 0.0103
357 GENERAL PHYSICAL HEALTH DETERIORATION 1190 0.0103
358 ACUTE MYELOID LEUKAEMIA 160 0.0103
359 ANGINA PECTORIS 293 0.0102
360 LUNG INFILTRATION 90 0.0102
361 ASTHENOPIA 56 0.0102
362 PULMONARY THROMBOSIS 111 0.0102
363 DERMATITIS 213 0.0102
364 HEPATIC STEATOSIS 189 0.0101
365 SEPTIC SHOCK 439 0.0101
366 INTERSTITIAL LUNG DISEASE 488 0.0101
367 HEPATIC ENCEPHALOPATHY 93 0.0100
368 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 95 0.0099
369 CHAPPED LIPS 43 0.0099
370 LYMPHOPENIA 140 0.0099
371 CENTRAL NERVOUS SYSTEM LESION 136 0.0099
372 CARDIOGENIC SHOCK 142 0.0099
373 CHOLESTASIS 190 0.0099
374 NECROSIS 55 0.0099
375 PARAESTHESIA 1554 0.0099
376 DYSPHAGIA 937 0.0099
377 FAECALOMA 54 0.0098
378 ABDOMINAL PAIN 2291 0.0098
379 METABOLIC DISORDER 57 0.0098
380 PHLEBITIS 50 0.0098
381 ALANINE AMINOTRANSFERASE INCREASED 597 0.0097
382 SKIN ULCER 251 0.0097
383 TRICUSPID VALVE INCOMPETENCE 77 0.0097
384 OSTEONECROSIS 318 0.0097
385 SPINAL OSTEOARTHRITIS 85 0.0097
386 GASTROENTERITIS 141 0.0097
387 FEBRILE BONE MARROW APLASIA 41 0.0096
388 HAEMOGLOBIN ABNORMAL 62 0.0096
389 PERITONITIS 199 0.0096
390 MULTI-ORGAN FAILURE 166 0.0096
391 MUSCULOSKELETAL CHEST PAIN 148 0.0096
392 APHTHOUS ULCER 74 0.0095
393 BLOOD CALCIUM DECREASED 107 0.0095
394 INTRACRANIAL PRESSURE INCREASED 53 0.0095
395 LACRIMATION INCREASED 287 0.0095
396 BLOOD LACTIC ACID INCREASED 50 0.0095
397 GRANULOCYTOPENIA 54 0.0095
398 BONE CANCER 41 0.0094
399 CHOLECYSTITIS 112 0.0094
400 APHAGIA 45 0.0093
401 BLOOD PRESSURE DIASTOLIC DECREASED 69 0.0093
402 CARDIOMYOPATHY 138 0.0093
403 HYPERGLYCAEMIA 340 0.0093
404 JAW DISORDER 51 0.0093
405 GASTRITIS 245 0.0093
406 HAEMATEMESIS 236 0.0093
407 IMPAIRED HEALING 305 0.0093
408 TOOTHACHE 168 0.0093
409 ANGINA UNSTABLE 60 0.0092
410 HYPERPYREXIA 39 0.0092
411 SENSORY LOSS 74 0.0092
412 DEEP VEIN THROMBOSIS 597 0.0092
413 ASTHENIA 3451 0.0092
414 HAEMOLYSIS 70 0.0091
415 DRY SKIN 1201 0.0090
416 FLUID INTAKE REDUCED 45 0.0090
417 TASTE DISORDER 182 0.0090
418 DEVICE RELATED INFECTION 138 0.0090
419 BUNDLE BRANCH BLOCK LEFT 38 0.0090
420 SPINAL PAIN 104 0.0089
421 CARDIAC FAILURE ACUTE 59 0.0088
422 BLOOD TEST ABNORMAL 123 0.0087
423 MITRAL VALVE INCOMPETENCE 99 0.0087
424 EPISTAXIS 654 0.0087
425 MOUTH HAEMORRHAGE 64 0.0087
426 CONSTIPATION 1902 0.0087
427 TROPONIN INCREASED 66 0.0087
428 HEPATOMEGALY 85 0.0086
429 BREAST MASS 58 0.0086
430 SKIN DISORDER 288 0.0086
431 BONE PAIN 505 0.0086
432 BLOOD DISORDER 69 0.0086
433 WOUND INFECTION 94 0.0086
434 BLOOD PRESSURE SYSTOLIC DECREASED 39 0.0086
435 NEUROLOGICAL SYMPTOM 49 0.0086
436 RED BLOOD CELL COUNT DECREASED 245 0.0086
437 HYPOAESTHESIA 1276 0.0085
438 THROMBOSIS 683 0.0085
439 CEREBRAL INFARCTION 207 0.0085
440 PERIPHERAL COLDNESS 116 0.0084
441 FATIGUE 6570 0.0084
442 MYELODYSPLASTIC SYNDROME 122 0.0084
443 HYPERNATRAEMIA 42 0.0084
444 HYPERCALCAEMIA 104 0.0084
445 EATING DISORDER 179 0.0084
446 FEMORAL NECK FRACTURE 43 0.0084
447 HYPONATRAEMIA 472 0.0084
448 HEMIPARESIS 141 0.0083
449 HEPATOCELLULAR INJURY 118 0.0083
450 NEUTROPHILIA 47 0.0083
451 LIVER DISORDER 364 0.0082
452 VEIN DISORDER 41 0.0082
453 PULMONARY OEDEMA 366 0.0082
454 ERYSIPELAS 41 0.0082
455 INTENTIONAL PRODUCT USE ISSUE 711 0.0081
456 SKIN NECROSIS 42 0.0081
457 RALES 47 0.0081
458 BLOOD SODIUM DECREASED 152 0.0081
459 GUILLAIN-BARRE SYNDROME 39 0.0081
460 ABDOMINAL TENDERNESS 40 0.0080
461 BRONCHOSPASM 114 0.0080
462 FEEDING DISORDER 162 0.0080
463 CHOLECYSTITIS ACUTE 45 0.0079
464 ACUTE MYOCARDIAL INFARCTION 233 0.0079
465 ANAL FISTULA 42 0.0079
466 DECUBITUS ULCER 64 0.0078
467 GASTROINTESTINAL DISORDER 703 0.0078
468 RASH PUSTULAR 57 0.0078
469 RENAL CYST 62 0.0078
470 DRUG-INDUCED LIVER INJURY 243 0.0077
471 DRUG TOXICITY 105 0.0077
472 C-REACTIVE PROTEIN INCREASED 279 0.0077
473 ABSCESS 122 0.0076
474 BLOOD UREA INCREASED 128 0.0076
475 SKIN MASS 51 0.0076
476 DRUG RESISTANCE 196 0.0076
477 MULTIPLE ORGAN DYSFUNCTION SYNDROME 216 0.0076
478 THERMAL BURN 54 0.0076
479 PLATELET COUNT ABNORMAL 46 0.0076
480 ILL-DEFINED DISORDER 462 0.0076
481 SENSORY DISTURBANCE 121 0.0075
482 BREAST PAIN 80 0.0075
483 IRON DEFICIENCY ANAEMIA 69 0.0075
484 INCONTINENCE 79 0.0075
485 TOOTH ABSCESS 76 0.0075
486 TONGUE DISORDER 54 0.0075
487 LIPASE INCREASED 57 0.0074
488 WEIGHT DECREASED 2069 0.0074
489 LEUKOCYTOSIS 134 0.0074
490 ORAL CANDIDIASIS 97 0.0074
491 DRUG INTOLERANCE 711 0.0074
492 CYTOPENIA 90 0.0073
493 NEOPLASM MALIGNANT 487 0.0073
494 HYPERLIPIDAEMIA 87 0.0073
495 RENAL FAILURE ACUTE 307 0.0072
496 ERYTHEMA 1486 0.0072
497 NEUTROPHIL COUNT INCREASED 74 0.0072
498 LIVER FUNCTION TEST INCREASED 155 0.0072
499 PYREXIA 2495 0.0072
500 UROSEPSIS 66 0.0071
501 BLOOD CREATININE INCREASED 466 0.0071
502 HAEMORRHOIDS 139 0.0071
503 DECREASED INTEREST 42 0.0071
504 WEIGHT FLUCTUATION 74 0.0071
505 HAEMATOCRIT DECREASED 139 0.0070
506 EPILEPSY 214 0.0070
507 EYELID PTOSIS 71 0.0070
508 URINE ODOUR ABNORMAL 41 0.0070
509 ACIDOSIS 53 0.0069
510 GASTROINTESTINAL INFECTION 62 0.0069
511 MYOSITIS 62 0.0069
512 RECTAL HAEMORRHAGE 293 0.0068
513 LARYNGEAL OEDEMA 42 0.0068
514 ULCER 108 0.0068
515 APPETITE DISORDER 45 0.0068
516 HYPOAESTHESIA ORAL 102 0.0068
517 DISEASE RECURRENCE 321 0.0067
518 SINUS TACHYCARDIA 95 0.0067
519 HYPERTHERMIA 51 0.0067
520 HEPATIC CIRRHOSIS 125 0.0066
521 RETINAL DETACHMENT 61 0.0066
522 DYSURIA 244 0.0066
523 FLANK PAIN 62 0.0066
524 NEPHROPATHY TOXIC 74 0.0066
525 RENAL IMPAIRMENT 553 0.0066
526 INFECTION 950 0.0066
527 HYPERTENSIVE CRISIS 73 0.0066
528 ANAL INCONTINENCE 59 0.0066
529 DENTAL CARIES 72 0.0065
530 OEDEMA PERIPHERAL 793 0.0065
531 ABDOMINAL DISTENSION 677 0.0065
532 HYPERCHOLESTEROLAEMIA 62 0.0064
533 UPPER GASTROINTESTINAL HAEMORRHAGE 108 0.0064
534 HAEMOGLOBIN DECREASED 659 0.0064
535 CONJUNCTIVITIS 119 0.0064
536 RESPIRATORY FAILURE 466 0.0064
537 DYSARTHRIA 240 0.0064
538 HEMIPLEGIA 53 0.0064
539 MYOCARDITIS 73 0.0064
540 BURNING SENSATION 446 0.0064
541 FEELING COLD 177 0.0064
542 IMMUNOSUPPRESSION 56 0.0063
543 SKIN LESION 174 0.0063
544 RETCHING 135 0.0063
545 CARDIAC ARREST 520 0.0063
546 WHITE BLOOD CELL COUNT ABNORMAL 40 0.0063
547 NEURALGIA 152 0.0062
548 TOXICITY TO VARIOUS AGENTS 1054 0.0062
549 AGRANULOCYTOSIS 116 0.0062
550 OEDEMA 338 0.0062
551 PNEUMONIA ASPIRATION 155 0.0062
552 METABOLIC ACIDOSIS 197 0.0062
553 DYSGEUSIA 455 0.0061
554 ASPIRATION 67 0.0061
555 CHEST PAIN 1131 0.0061
556 FULL BLOOD COUNT DECREASED 123 0.0061
557 LETHARGY 350 0.0061
558 SPINAL COMPRESSION FRACTURE 50 0.0060
559 CLOSTRIDIUM DIFFICILE COLITIS 64 0.0060
560 PAIN IN EXTREMITY 1778 0.0060
561 ACUTE RESPIRATORY DISTRESS SYNDROME 106 0.0060
562 NO THERAPEUTIC RESPONSE 73 0.0060
563 DIPLOPIA 155 0.0060
564 SHOCK 137 0.0060
565 DERMATITIS BULLOUS 43 0.0059
566 HAEMODYNAMIC INSTABILITY 45 0.0059
567 FAECES DISCOLOURED 128 0.0059
568 ISCHAEMIC STROKE 105 0.0059
569 LIVER FUNCTION TEST ABNORMAL 171 0.0059
570 HEPATIC ENZYME INCREASED 400 0.0059
571 TOOTH DISORDER 130 0.0058
572 ORAL DISCOMFORT 81 0.0058
573 TOOTH FRACTURE 64 0.0058
574 CARDIOMEGALY 71 0.0058
575 GASTROINTESTINAL PAIN 63 0.0057
576 PULMONARY FIBROSIS 109 0.0057
577 RENAL FAILURE 754 0.0057
578 GASTRIC HAEMORRHAGE 65 0.0056
579 INTERVERTEBRAL DISC DEGENERATION 52 0.0056
580 DEVICE OCCLUSION 79 0.0056
581 ELECTROCARDIOGRAM ABNORMAL 44 0.0056
582 HYPOTHYROIDISM 179 0.0056
583 GASTROINTESTINAL HAEMORRHAGE 468 0.0056
584 DYSPEPSIA 549 0.0056
585 ABDOMINAL PAIN UPPER 1147 0.0056
586 TOXIC SKIN ERUPTION 56 0.0056
587 ADRENAL INSUFFICIENCY 67 0.0055
588 LOCAL SWELLING 96 0.0055
589 CELLULITIS 277 0.0055
590 HYPERTENSION 1153 0.0054
591 HEPATITIS 139 0.0054
592 INFUSION RELATED REACTION 359 0.0054
593 ENCEPHALOPATHY 133 0.0054
594 HIATUS HERNIA 70 0.0054
595 HAEMATURIA 185 0.0054
596 HYPOXIA 190 0.0054
597 TRANSIENT ISCHAEMIC ATTACK 182 0.0054
598 CHOLELITHIASIS 176 0.0054
599 GASTRIC ULCER 102 0.0054
600 DYSPNOEA EXERTIONAL 201 0.0053
601 UTERINE LEIOMYOMA 39 0.0053
602 PSYCHOLOGICAL TRAUMA 46 0.0053
603 CHILLS 624 0.0053
604 DYSPHONIA 310 0.0053
605 EOSINOPHIL COUNT INCREASED 44 0.0053
606 MELAENA 116 0.0053
607 RASH MACULO-PAPULAR 117 0.0053
608 ERYTHEMA MULTIFORME 49 0.0052
609 HAEMORRHAGE 548 0.0052
610 RASH 2282 0.0052
611 PLATELET COUNT INCREASED 68 0.0052
612 VENTRICULAR TACHYCARDIA 86 0.0052
613 PARAESTHESIA ORAL 75 0.0052
614 CLOSTRIDIUM DIFFICILE INFECTION 113 0.0052
615 PELVIC PAIN 94 0.0052
616 ALTERED STATE OF CONSCIOUSNESS 112 0.0052
617 FLATULENCE 293 0.0052
618 PANCREATITIS ACUTE 116 0.0052
619 SHOCK HAEMORRHAGIC 42 0.0052
620 RIB FRACTURE 106 0.0051
621 PELVIC FRACTURE 40 0.0051
622 CARDIAC FAILURE 411 0.0051
623 MENTAL STATUS CHANGES 142 0.0051
624 CEREBRAL HAEMORRHAGE 183 0.0051
625 TACHYCARDIA 453 0.0051
626 BODY TEMPERATURE INCREASED 104 0.0051
627 ABNORMAL FAECES 41 0.0050
628 PANCREATIC CARCINOMA 144 0.0050
629 BACTERIAL INFECTION 93 0.0050
630 MUSCLE ATROPHY 63 0.0050
631 ORAL HERPES 97 0.0050
632 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 51 0.0050
633 LOCALISED INFECTION 120 0.0050
634 CYSTITIS 158 0.0050
635 PERIPHERAL SWELLING 763 0.0049
636 ALOPECIA 972 0.0049
637 STEVENS-JOHNSON SYNDROME 110 0.0049
638 IMMUNE SYSTEM DISORDER 65 0.0049
639 TACHYPNOEA 67 0.0049
640 FREQUENT BOWEL MOVEMENTS 133 0.0049
641 INFLAMMATION 254 0.0049
642 IMPAIRED GASTRIC EMPTYING 67 0.0049
643 HYPERKALAEMIA 172 0.0049
644 NODULE 64 0.0049
645 HOSPITALISATION 751 0.0049
646 ARTERIOSCLEROSIS 46 0.0049
647 BLOOD URINE PRESENT 92 0.0048
648 FACIAL PARALYSIS 41 0.0048
649 BLOOD PRESSURE DECREASED 319 0.0048
650 GENERALISED OEDEMA 59 0.0048
651 DYSPNOEA 2695 0.0048
652 FRACTURE 90 0.0047
653 ARRHYTHMIA 225 0.0047
654 MYOPATHY 41 0.0047
655 URINARY RETENTION 158 0.0047
656 INTERNATIONAL NORMALISED RATIO INCREASED 135 0.0047
657 BACK PAIN 1088 0.0047
658 LACERATION 44 0.0047
659 MUSCULOSKELETAL PAIN 245 0.0047
660 GROIN PAIN 41 0.0047
661 SPEECH DISORDER 244 0.0047
662 HYPOTENSION 934 0.0047
663 WHITE BLOOD CELL COUNT INCREASED 178 0.0046
664 LYMPHOCYTE COUNT DECREASED 82 0.0046
665 IMMUNODEFICIENCY 69 0.0046
666 LIP DRY 42 0.0046
667 PHARYNGITIS 57 0.0046
668 ORTHOSTATIC HYPOTENSION 80 0.0046
669 SYNCOPE 459 0.0046
670 WOUND 128 0.0046
671 GASTRIC CANCER 116 0.0046
672 BLOOD THYROID STIMULATING HORMONE INCREASED 42 0.0046
673 EMPHYSEMA 46 0.0046
674 GASTROOESOPHAGEAL REFLUX DISEASE 365 0.0045
675 ACUTE KIDNEY INJURY 691 0.0045
676 DRY MOUTH 365 0.0045
677 TRANSFUSION 47 0.0045
678 ABASIA 110 0.0044
679 OFF LABEL USE 3895 0.0044
680 HAEMOPTYSIS 124 0.0044
681 URINARY TRACT INFECTION 757 0.0044
682 NERVOUS SYSTEM DISORDER 138 0.0044
683 PETECHIAE 46 0.0044
684 CARDIO-RESPIRATORY ARREST 182 0.0043
685 ATRIAL FIBRILLATION 419 0.0043
686 PERICARDITIS 72 0.0043
687 PNEUMONIA 1375 0.0042
688 HIP ARTHROPLASTY 65 0.0042
689 DRY THROAT 43 0.0042
690 LUNG DISORDER 207 0.0042
691 EAR PAIN 82 0.0042
692 THROAT TIGHTNESS 114 0.0042
693 BLOOD IRON DECREASED 50 0.0042
694 CHROMATURIA 95 0.0042
695 ELECTROCARDIOGRAM QT PROLONGED 151 0.0042
696 SUPRAVENTRICULAR TACHYCARDIA 40 0.0042
697 IMPAIRED QUALITY OF LIFE 60 0.0042
698 STATUS EPILEPTICUS 47 0.0042
699 GAIT INABILITY 138 0.0041
700 HAEMATOCHEZIA 227 0.0041
701 ABDOMINAL PAIN LOWER 104 0.0041
702 HYPOGLYCAEMIA 199 0.0041
703 OVARIAN CYST 41 0.0041
704 MALAISE 1792 0.0041
705 PNEUMOCYSTIS JIROVECII PNEUMONIA 41 0.0041
706 ERUCTATION 79 0.0041
707 APHASIA 123 0.0041
708 PARALYSIS 58 0.0040
709 BALANCE DISORDER 350 0.0040
710 COORDINATION ABNORMAL 56 0.0040
711 ACUTE RESPIRATORY FAILURE 77 0.0040
712 ADVERSE REACTION 53 0.0040
713 PHOTOSENSITIVITY REACTION 66 0.0040
714 MUSCLE SPASMS 730 0.0040
715 DEAFNESS 104 0.0040
716 TOOTH LOSS 82 0.0040
717 OSTEOPENIA 60 0.0039
718 APHONIA 55 0.0039
719 INTERVERTEBRAL DISC PROTRUSION 86 0.0039
720 AGEUSIA 98 0.0039
721 MUSCULAR WEAKNESS 445 0.0039
722 DRY EYE 195 0.0039
723 COMA 185 0.0039
724 RESPIRATORY DISTRESS 107 0.0039
725 LIP SWELLING 129 0.0039
726 BURSITIS 47 0.0039
727 CONFUSIONAL STATE 626 0.0039
728 TOOTH INFECTION 51 0.0039
729 VENTRICULAR EXTRASYSTOLES 40 0.0038
730 DIABETIC KETOACIDOSIS 92 0.0038
731 CHEST DISCOMFORT 389 0.0038
732 NO ADVERSE EVENT 686 0.0038
733 MUSCULOSKELETAL DISORDER 72 0.0038
734 THERAPY NON-RESPONDER 170 0.0038
735 DELIRIUM 131 0.0038
736 POOR VENOUS ACCESS 39 0.0038
737 HEART RATE DECREASED 132 0.0038
738 LIMB DISCOMFORT 116 0.0037
739 COUGH 1050 0.0037
740 SKIN INFECTION 42 0.0037
741 BREAST CANCER FEMALE 100 0.0037
742 LUNG INFECTION 58 0.0037
743 MUSCLE TWITCHING 86 0.0037
744 CONVULSION 213 0.0037
745 PAIN OF SKIN 100 0.0037
746 SKIN HAEMORRHAGE 55 0.0037
747 SARS-COV-2 TEST POSITIVE 49 0.0037
748 POST PROCEDURAL HAEMORRHAGE 43 0.0037
749 BLOOD COUNT ABNORMAL 56 0.0037
750 NIGHT SWEATS 119 0.0037
751 HYPERSENSITIVITY 685 0.0037
752 SKIN LACERATION 40 0.0037
753 ABDOMINAL DISCOMFORT 614 0.0037
754 UPPER RESPIRATORY TRACT INFECTION 169 0.0037
755 GAIT DISTURBANCE 700 0.0037
756 BEDRIDDEN 48 0.0036
757 BLOOD POTASSIUM INCREASED 59 0.0036
758 HEPATIC CANCER 87 0.0036
759 RENAL DISORDER 168 0.0036
760 PAIN 2212 0.0036
761 HEART RATE IRREGULAR 81 0.0036
762 DISORIENTATION 142 0.0036
763 HYPERSOMNIA 102 0.0036
764 HERPES ZOSTER 204 0.0035
765 URINARY INCONTINENCE 105 0.0035
766 BLOOD CREATINE PHOSPHOKINASE INCREASED 102 0.0035
767 PANCREATITIS 187 0.0035
768 PALLOR 96 0.0035
769 GASTRIC DISORDER 121 0.0035
770 CARDIAC DISORDER 327 0.0035
771 VISUAL ACUITY REDUCED 116 0.0035
772 TOXIC EPIDERMAL NECROLYSIS 53 0.0035
773 POST PROCEDURAL COMPLICATION 67 0.0035
774 BLOOD PRESSURE SYSTOLIC INCREASED 68 0.0035
775 INJECTION SITE EXTRAVASATION 43 0.0035
776 FACE OEDEMA 58 0.0034
777 SCAB 39 0.0034
778 DRUG INTERACTION 539 0.0034
779 UNEVALUABLE EVENT 256 0.0034
780 NOCTURIA 41 0.0034
781 SWELLING 315 0.0034
782 COLD SWEAT 59 0.0033
783 DRUG ERUPTION 59 0.0033
784 PULMONARY HYPERTENSION 69 0.0033
785 DIZZINESS 1647 0.0033
786 ANAPHYLACTIC REACTION 182 0.0033
787 ACUTE HEPATIC FAILURE 45 0.0033
788 TREATMENT FAILURE 270 0.0033
789 NECK PAIN 181 0.0032
790 LABORATORY TEST ABNORMAL 95 0.0032
791 UNRESPONSIVE TO STIMULI 83 0.0032
792 STAPHYLOCOCCAL INFECTION 106 0.0032
793 DEPRESSED LEVEL OF CONSCIOUSNESS 127 0.0032
794 SWOLLEN TONGUE 100 0.0032
795 VERTIGO 195 0.0032
796 DEPRESSED MOOD 169 0.0032
797 CYANOSIS 50 0.0032
798 RASH MACULAR 110 0.0031
799 SCIATICA 50 0.0031
800 FEMUR FRACTURE 97 0.0031
801 SURGERY 183 0.0031
802 RASH ERYTHEMATOUS 149 0.0031
803 HYPERTHYROIDISM 45 0.0031
804 PRODUCTIVE COUGH 148 0.0031
805 FEELING HOT 190 0.0031
806 ADVERSE DRUG REACTION 277 0.0031
807 FOOT FRACTURE 58 0.0031
808 QUALITY OF LIFE DECREASED 41 0.0031
809 MOVEMENT DISORDER 98 0.0030
810 BLOOD PRESSURE INCREASED 466 0.0030
811 PULMONARY CONGESTION 40 0.0030
812 RHINORRHOEA 196 0.0030
813 BLINDNESS 123 0.0030
814 RESPIRATORY DISORDER 90 0.0030
815 SPINAL FRACTURE 60 0.0030
816 HIP FRACTURE 96 0.0030
817 RESPIRATORY TRACT INFECTION 77 0.0030
818 OROPHARYNGEAL PAIN 273 0.0029
819 CONTUSION 283 0.0029
820 PALPITATIONS 344 0.0029
821 JOINT STIFFNESS 77 0.0029
822 SEIZURE 338 0.0029
823 POLLAKIURIA 122 0.0029
824 DIVERTICULITIS 81 0.0029
825 GENERALISED TONIC-CLONIC SEIZURE 48 0.0029
826 RASH PRURITIC 156 0.0029
827 GLOSSODYNIA 64 0.0029
828 FALL 951 0.0029
829 THIRST 51 0.0029
830 PRESYNCOPE 69 0.0028
831 LOWER RESPIRATORY TRACT INFECTION 129 0.0028
832 DIABETES MELLITUS 216 0.0028
833 SEASONAL ALLERGY 40 0.0028
834 MYALGIA 479 0.0028
835 ECZEMA 147 0.0028
836 DISCOMFORT 171 0.0028
837 LOSS OF CONSCIOUSNESS 356 0.0028
838 PHOTOPHOBIA 52 0.0028
839 CEREBROVASCULAR ACCIDENT 467 0.0028
840 MUSCLE TIGHTNESS 44 0.0027
841 NEPHROLITHIASIS 124 0.0027
842 SWELLING FACE 176 0.0027
843 HEART RATE INCREASED 266 0.0027
844 PRODUCT USE IN UNAPPROVED INDICATION 663 0.0027
845 DYSSTASIA 78 0.0027
846 HOT FLUSH 199 0.0026
847 COGNITIVE DISORDER 123 0.0026
848 THERAPEUTIC RESPONSE DECREASED 159 0.0026
849 MYOCARDIAL INFARCTION 456 0.0026
850 AMNESIA 170 0.0026
851 OXYGEN SATURATION DECREASED 146 0.0026
852 HEAD INJURY 82 0.0026
853 MUSCULOSKELETAL DISCOMFORT 44 0.0026
854 TREMOR 424 0.0026
855 FUNGAL INFECTION 85 0.0025
856 RESTLESSNESS 93 0.0025
857 HEADACHE 1588 0.0025
858 SLEEP DISORDER 178 0.0025
859 INSOMNIA 669 0.0025
860 RASH GENERALISED 65 0.0025
861 GOUT 45 0.0025
862 EYE DISORDER 82 0.0025
863 NASOPHARYNGITIS 457 0.0025
864 OSTEOARTHRITIS 105 0.0025
865 FLUSHING 250 0.0025
866 SNEEZING 55 0.0024
867 FLUID RETENTION 124 0.0024
868 HAEMATOMA 63 0.0024
869 THROAT IRRITATION 109 0.0024
870 BRAIN FOG 38 0.0024
871 MEMORY IMPAIRMENT 332 0.0024
872 VISUAL IMPAIRMENT 299 0.0024
873 PRURITUS 924 0.0024
874 TUBULOINTERSTITIAL NEPHRITIS 45 0.0024
875 SOMNOLENCE 481 0.0024
876 VISION BLURRED 327 0.0024
877 EMOTIONAL DISORDER 73 0.0024
878 MEDICATION ERROR 130 0.0023
879 SCAR 40 0.0023
880 BLOOD TRIGLYCERIDES INCREASED 41 0.0023
881 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 163 0.0023
882 PRODUCT ADMINISTRATION ERROR 46 0.0023
883 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 39 0.0023
884 ACNE 169 0.0022
885 ARTHRALGIA 925 0.0022
886 GASTROENTERITIS VIRAL 40 0.0022
887 ANAPHYLACTIC SHOCK 57 0.0022
888 LIMB INJURY 60 0.0022
889 GALLBLADDER DISORDER 39 0.0022
890 ILLNESS 224 0.0022
891 SINUS DISORDER 43 0.0022
892 HERNIA 41 0.0021
893 CATARACT 126 0.0021
894 ROAD TRAFFIC ACCIDENT 88 0.0021
895 RASH PAPULAR 47 0.0021
896 PRODUCT DOSE OMISSION IN ERROR 59 0.0021
897 HYPERHIDROSIS 268 0.0021
898 ANXIETY 591 0.0021
899 COVID-19 364 0.0021
900 TINNITUS 95 0.0021
901 POOR QUALITY SLEEP 44 0.0020
902 RESPIRATORY ARREST 56 0.0020
903 CORONARY ARTERY DISEASE 61 0.0020
904 DRUG INEFFECTIVE 2654 0.0020
905 UPPER LIMB FRACTURE 40 0.0020
906 SKIN CANCER 43 0.0020
907 NEEDLE ISSUE 58 0.0020
908 CARDIAC FAILURE CONGESTIVE 159 0.0020
909 RHABDOMYOLYSIS 82 0.0020
910 LUNG NEOPLASM MALIGNANT 80 0.0019
911 BRONCHITIS 144 0.0019
912 PRODUCT PRESCRIBING ISSUE 42 0.0019
913 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 100 0.0019
914 EYE IRRITATION 110 0.0019
915 ANHEDONIA 50 0.0019
916 TYPE 2 DIABETES MELLITUS 64 0.0019
917 WEIGHT INCREASED 420 0.0019
918 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 90 0.0019
919 OSTEOPOROSIS 77 0.0019
920 MOBILITY DECREASED 133 0.0018
921 MUSCULOSKELETAL STIFFNESS 161 0.0018
922 RENAL INJURY 54 0.0018
923 WHEEZING 107 0.0018
924 BRADYCARDIA 95 0.0018
925 BLOOD CHOLESTEROL INCREASED 82 0.0018
926 INJURY 123 0.0017
927 ADVERSE EVENT 161 0.0017
928 SINUSITIS 178 0.0017
929 VIRAL INFECTION 57 0.0017
930 DEPRESSION 389 0.0017
931 ARTHROPATHY 95 0.0017
932 EYE SWELLING 63 0.0017
933 INTENTIONAL DOSE OMISSION 48 0.0017
934 CARDIOVASCULAR DISORDER 42 0.0017
935 FEELING ABNORMAL 390 0.0016
936 OESOPHAGEAL CARCINOMA 48 0.0016
937 JOINT SWELLING 195 0.0016
938 MENTAL DISORDER 70 0.0016
939 CONDITION AGGRAVATED 488 0.0016
940 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 289 0.0016
941 ANGIOEDEMA 70 0.0016
942 EYE PRURITUS 53 0.0016
943 COLORECTAL CANCER 75 0.0016
944 FEAR 42 0.0016
945 INFLUENZA LIKE ILLNESS 126 0.0015
946 OCULAR HYPERAEMIA 72 0.0015
947 LACTIC ACIDOSIS 49 0.0015
948 HALLUCINATION 114 0.0015
949 UNDERDOSE 110 0.0015
950 MOOD ALTERED 41 0.0015
951 VAGINAL HAEMORRHAGE 65 0.0015
952 EYE PAIN 84 0.0015
953 HYPOACUSIS 63 0.0015
954 ARTHRITIS 115 0.0015
955 PRODUCT USE ISSUE 274 0.0015
956 DRUG ADMINISTRATION ERROR 44 0.0014
957 DRUG EFFECT DECREASED 76 0.0014
958 CRYING 51 0.0014
959 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 77 0.0014
960 ACCIDENTAL OVERDOSE 51 0.0014
961 COLITIS ULCERATIVE 62 0.0014
962 TREATMENT NONCOMPLIANCE 75 0.0014
963 AGITATION 100 0.0014
964 SKIN IRRITATION 61 0.0013
965 INJECTION SITE MASS 49 0.0013
966 BLOOD GLUCOSE INCREASED 249 0.0013
967 BLOOD GLUCOSE DECREASED 63 0.0013
968 URTICARIA 213 0.0013
969 SKIN BURNING SENSATION 91 0.0013
970 DRUG EFFECT INCOMPLETE 46 0.0013
971 INFLUENZA 133 0.0012
972 DISTURBANCE IN ATTENTION 64 0.0012
973 DYSKINESIA 48 0.0012
974 MIGRAINE 108 0.0011
975 PRODUCT DOSE OMISSION ISSUE 323 0.0011
976 IRRITABILITY 63 0.0010
977 NASAL CONGESTION 60 0.0010
978 ASTHMA 111 0.0010
979 THERAPEUTIC RESPONSE UNEXPECTED 42 0.0009
980 OVERDOSE 182 0.0008
981 NERVOUSNESS 41 0.0008
982 INTENTIONAL PRODUCT MISUSE 67 0.0008
983 EMOTIONAL DISTRESS 91 0.0008
984 PRODUCT DOSE OMISSION 45 0.0007
985 DRUG DOSE OMISSION 109 0.0007
986 INJECTION SITE SWELLING 50 0.0007
987 CHRONIC KIDNEY DISEASE 48 0.0006
988 INCORRECT DOSE ADMINISTERED 130 0.0006
989 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 40 0.0006
990 INJECTION SITE ERYTHEMA 66 0.0005
991 SUICIDAL IDEATION 47 0.0005
992 PRODUCT QUALITY ISSUE 60 0.0004
993 INJECTION SITE PAIN 135 0.0004
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 72 0.0004